about
Sex Differences and Functional Outcome After Intravenous Thrombolysis.A series of Greek children with pure hereditary spastic paraplegia: clinical features and genetic findings.Acute Ischemic Stroke in Nonconvulsive Status Epilepticus-Underestimated? Results from an Eight-Year Cohort Study.Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.Frequency and Determinants of Adherence to Oral Anticoagulants in Stroke Patients with Atrial Fibrillation in Clinical Practice.Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke.Early start of DOAC after ischemic stroke: Risk of intracranial hemorrhage and recurrent events.Impact of body mass index on outcome in stroke patients treated with intravenous thrombolysis.Intravenous thrombolysis and platelet count.Transient focal neurologic deficits upon hematopoietic stem cell transplantation: just a coincidence?A Score for Risk of Thrombolysis-Associated Hemorrhage Including Pretreatment with Statins.Management of patients with stroke treated with direct oral anticoagulantsRivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trialProtocol for MAAESTRO: Electronic Monitoring and Improvement of Adherence to Direct Oral Anticoagulant Treatment-A Randomized Crossover Study of an Educational and Reminder-Based Intervention in Ischemic STROke Patients Under PolypharmacyDirect oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation.Fast-track versus long-term hospitalizations for patients with non-disabling acute ischaemic strokeSmall vessel disease is associated with an unfavourable outcome in stroke patients on oral anticoagulationArtery occlusion independently predicts unfavorable outcome in cervical artery dissectionDevelopment and Validation of a Prognostic Model of Swallowing Recovery and Enteral Tube Feeding After Ischemic StrokeCerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studiesIntravenous thrombolysis for suspected ischemic stroke with seizure at onsetCauses and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
P50
Q38988162-1C5CA4E1-0D3A-4A2C-B259-BABB804D1D69Q39711023-AED817E8-365C-44A1-9B38-0C15AF78D7E3Q42210140-B146E0F8-2CCC-4E57-A859-DFBCA0FA0BD8Q42380272-7B05AB84-F23C-4F0B-A6D2-8548544C0C6BQ47711789-BEDC3099-7DDE-44DD-A02D-AC62FE2B935DQ47823322-C7629319-AF39-4135-9955-867C42C7C7AEQ47978696-E9153944-7565-4CB5-A517-9A5D8DA9B057Q47989628-133BF57D-A747-4CEC-98FD-981EC57500D2Q48448515-49EFED59-5E46-4413-83B5-248D026EE10AQ48592895-250FB773-3ECB-4E8F-B31F-B38C2F7993FDQ49788354-4590F8C9-FACE-450D-8242-64BBD102C685Q50086234-949B55E5-7B22-451F-9241-7C5C1C65B697Q51765845-1DB8020F-4AB2-4701-B724-4679F959B98BQ57183611-52D31B35-5C07-4174-974E-328A67AF5C78Q58300662-B8EF8FB9-3D01-4F20-BB67-DE7292526AF3Q60938785-02C39535-EDBD-4464-AE03-1963485C8747Q64898101-AD45BFE2-CBE4-46F1-B1C9-12983ABBC23CQ90411551-5D2313A5-B391-4B30-A68A-DFAF89980DCAQ90783053-FD25CCF4-C546-461E-A6AD-5C50B4C65C7DQ91404018-BFC5021E-D8B0-4A81-A318-65D5948403A8Q91451875-D8B51C6F-31E1-4157-999E-5EDE798EBEDEQ92304046-0682C4AA-2180-4A15-AEF4-690425A10CFCQ92764397-A4C049BA-F8A0-4516-8B12-037DE42D34D6Q92992716-375F336C-7848-4840-9B16-85F1CD478BF1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Polymeris
@ast
A Polymeris
@en
A Polymeris
@es
A Polymeris
@nl
type
label
A Polymeris
@ast
A Polymeris
@en
A Polymeris
@es
A Polymeris
@nl
altLabel
Alexandros Polymeris
@en
prefLabel
A Polymeris
@ast
A Polymeris
@en
A Polymeris
@es
A Polymeris
@nl
P106
P21
P31
P496
0000-0002-9475-2208